62
Participants
Start Date
August 31, 2006
Primary Completion Date
January 31, 2011
Study Completion Date
April 30, 2011
pentoxifylline
Oral pentoxifylline 1,200 mg/day (for estimated GFR ≧60 ml/min) or 800 mg/day (estimated GFR 59-30 ml/min) x 6 months, followed by stepwise reduction (800 mg/day x 6 M, 400 mg/day x 6 M and discontinued at 18 M
Corticosteroid
Oral prednisolone (1 mg/kg/day) x 3 M, followed by gradual tapering (0.5 mg/kg/day at 6 M, 0.25 mg/day at 12 M, and discontinued at 18 M
National Taiwan University Hospital, Taipei
National Science and Technology Council, Taiwan
OTHER_GOV
National Taiwan University Hospital
OTHER